1. SARS-CoV-2 pathogenesis;Lamers;Nat. Rev. Microbiol.,2022
2. Toll-like receptor 4 in COVID-19: friend or foe?;Mukherjee;Future Virol.,2022
3. Chemotherapy vs. Immunotherapy in combating nCOVID19: an update;Choudhury;Hum. Immunol.,2021
4. In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein;Das,2022
5. The humoral response and antibodies against SARS-CoV-2 infection;Qi;Nat. Immunol.,2022